News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sigmoid Pharma Completes Phase II Trial of CyCol™ in More than 100 Ulcerative Colitis Patients and Raises €3 Million


5/17/2012 10:01:54 AM

DUBLIN--(BUSINESS WIRE)--Sigmoid Pharma Ltd. (Sigmoid), a privately-owned, specialty pharmaceutical and drug delivery company registered in Ireland, today provides an update on significant progress in 2011 and 2012. Sigmoid’s AGM takes place today at 5 pm GMT

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES